GPCR19
GPCR19(G 蛋白偶联受体19)
GPCR19 is a G protein-coupled receptor for bile acid. Activation of this receptor induces its internalization and the production of intreacelluar cAMP. It is Involved in the suppression of macrophage function and regulation of energy homeostasis.
GPCR19 相关产品(12)
- GC33762Deoxycholic acid (Cholanoic Acid)CAS: 83-44-3纯度: >98.00%
Deoxycholic acid (Cholanoic Acid)是一种胆汁酸,肠道代谢副产物,可以激活G 蛋白偶联胆汁酸受体TGR5。
- GC33768Deoxycholic acid sodium salt (Sodium deoxycholate)CAS: 302-95-4纯度: >99.00%
Deoxycholic acid sodium salt (Sodium deoxycholate)是一种胆汁酸,是肠道代谢的副产物,可激活 G 蛋白偶联胆汁酸受体 TGR5。
- GC36319INT-777 R-enantiomerCAS: 1198786-98-9
INT-777 R-enantiomer 是 INT-77 的 R 型异构体,对 TGR5 的 EC50 值为 4.79 μM,活性比 INT-777 低。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16363 | TGR5 Receptor Agonist | 1197300-24-5 | >99.50% | |
A TGR5 agonist | ||||
| GC30565 | BAR502 | 1612191-86-2 | >98.00% | |
A dual agonist of GP-BAR1 and FXR | ||||
| GC31370 | SB756050 | 447410-57-3 | >99.00% | |
A TGR5 agonist | ||||
| GC32742 | INT-767 | 1000403-03-1 | >98.00% | |
INT-767是一种强效的法尼醇X受体(FXR)和Takeda G蛋白偶联受体5(TGR5)双重激动剂,EC 50 值分别为30nM和630nM。 | ||||
| GC33762 | Deoxycholic acid (Cholanoic Acid) | 83-44-3 | >98.00% | |
Deoxycholic acid (Cholanoic Acid)是一种胆汁酸,肠道代谢副产物,可以激活G 蛋白偶联胆汁酸受体TGR5。 | ||||
| GC33768 | Deoxycholic acid sodium salt (Sodium deoxycholate) | 302-95-4 | >99.00% | |
Deoxycholic acid sodium salt (Sodium deoxycholate)是一种胆汁酸,是肠道代谢的副产物,可激活 G 蛋白偶联胆汁酸受体 TGR5。 | ||||
| GC34775 | SBI-115 | 882366-16-7 | >99.50% / >98.00% | |
SBI-115是一种G蛋白胆汁酸偶联受体1(TGR5;GPCR19)拮抗剂。 | ||||
| GC36319 | INT-777 R-enantiomer | 1198786-98-9 | - | |
INT-777 R-enantiomer 是 INT-77 的 R 型异构体,对 TGR5 的 EC50 值为 4.79 μM,活性比 INT-777 低。 | ||||
| GC40637 | BAR501 | 1632118-69-4 | >98.00% | |
A selective GP-BAR1 agonist | ||||
| GC46012 | DY 268 | 1609564-75-1 | >98.00% | |
An FXR antagonist | ||||
| GN10489 | Hyodeoxycholic acid | 83-49-8 | >99.00% | |
A secondary bile acid | ||||
| GC13681 | INT-777 | 1199796-29-6 | >98.00% | |
INT-777 是一种新型特异性半合成 TGR5 激动剂,用于减轻 AD 小鼠模型的心肌细胞损伤,改善认知障碍和突触功能障碍。 | ||||
